MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 31 filers reported holding MILESTONE PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $66,294 | -34.2% | 23,261 | -9.1% | 0.00% | – |
| Q1 2023 | $100,809 | -71.3% | 25,586 | -71.2% | 0.00% | – |
| Q4 2022 | $351,252 | -89.3% | 88,700 | -75.1% | 0.00% | -100.0% |
| Q3 2022 | $3,278,000 | +1862.9% | 356,708 | +1163.4% | 0.00% | – |
| Q2 2022 | $167,000 | +135.2% | 28,233 | +154.4% | 0.00% | – |
| Q1 2022 | $71,000 | -64.1% | 11,100 | -67.9% | 0.00% | – |
| Q3 2021 | $198,000 | -65.8% | 34,600 | -67.1% | 0.00% | – |
| Q2 2021 | $579,000 | +8.0% | 105,200 | +13.6% | 0.00% | – |
| Q1 2021 | $536,000 | +294.1% | 92,600 | +356.4% | 0.00% | – |
| Q4 2020 | $136,000 | – | 20,288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 2,530,585 | $16,955,000 | 0.73% |
| Ikarian Capital, LLC | 1,836,545 | $12,305,000 | 0.54% |
| Boxer Capital, LLC | 2,477,194 | $16,597,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,911,000 | 0.48% |
| RA Capital Management | 2,327,714 | $15,596,000 | 0.22% |
| Orbimed Advisors | 2,493,109 | $16,704,000 | 0.15% |
| PURA VIDA INVESTMENTS, LLC | 450,000 | $3,015,000 | 0.11% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,704,000 | 0.08% |
| Anson Funds Management LP | 50,113 | $336,000 | 0.07% |
| Tekla Capital Management LLC | 253,610 | $1,699,000 | 0.06% |